AlzChem Group AG
XMUN:ACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
AlzChem Group AG
XMUN:ACT
|
DE |
|
Clavister Holding AB
F:89P
|
SE |
|
M
|
Melco International Development Ltd
OTC:MDEVF
|
HK |
Wall St Price Targets
ACT Price Targets Summary
AlzChem Group AG
According to Wall Street analysts, the average 1-year price target for ACT is 206.6 EUR with a low forecast of 175.94 EUR and a high forecast of 264.54 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ACT's stock price target?
Price Target
206.6
EUR
According to Wall Street analysts, the average 1-year price target for ACT is 206.6 EUR with a low forecast of 175.94 EUR and a high forecast of 264.54 EUR.
What is the Revenue forecast for AlzChem Group AG?
Projected CAGR
9%
Over the last 6 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 8 years is 9%.
What is the Gross Profit forecast for AlzChem Group AG?
Projected CAGR
12%
Over the last 6 years, the compound annual growth rate for Gross Profit has been 9%. The projected CAGR for the next 3 years is 12%.
What is the Operating Income forecast for AlzChem Group AG?
Projected CAGR
13%
Over the last 6 years, the compound annual growth rate for Operating Income has been 21%. The projected CAGR for the next 8 years is 13%.
What is the Pre-Tax Income forecast for AlzChem Group AG?
Projected CAGR
20%
Over the last 6 years, the compound annual growth rate for Pre-Tax Income has been 23%. The projected CAGR for the next 3 years is 20%.
What is the Net Income forecast for AlzChem Group AG?
Projected CAGR
20%
Over the last 6 years, the compound annual growth rate for Net Income has been 23%. The projected CAGR for the next 3 years is 20%.
